|
|
|
|
|
11.03.26 - 15:30
|
Citi Flags Agilent Technologies, Cuts Icon PLC Target, and More (24/7 Wall St.)
|
|
|
Citi swept through its life science tools and diagnostics coverage on Wednesday, opening a 90-day upside catalyst watch on Agilent Technologies (NYSE:A) while trimming its price target on Icon PLC (NASDAQ:ICLR) following a turbulent earnings season for the sector. Alongside those moves, the firm named Agilent its top tools pick, Natera (NASDAQ:NTRA) its top diagnostics ... Citi Flags Agilent Technologies, Cuts Icon PLC Target, and More
The post Citi Flags Agilent Technologies, Cuts Icon PLC Target, and More appeared first on 24/7 Wall St.....
|
|
|
|
|
|
|
|
|
|
|
|
|
09.03.26 - 08:06
|
Agilent to Acquire Biocare Medical, a Global Leader in Clinical and Research Pathology Solutions (Business Wire)
|
|
|
Expands Agilent's pathology portfolio through addition of highly complementary antibody, reagent and instrument business with annual double-digit revenue and profit growth since 2021
Expected to be accretive to Agilent's top-line growth rate, margin profile and non-instrument revenue mix in Year 1SANTA CLARA, Calif. & SAN FRANCISCO, Calif.--(BUSINESS WIRE)--$A #BringGreatScienceToLife--Agilent Technologies Inc. (NYSE: A) today announced it has entered into a definitive agreement to acquire Biocare Medical, a global leader in clinical pathology, from an investor group led by Excellere Partners and GHO Capital Partners LLP, in an all-cash transaction valued at $950 million.
Biocare is a high-growth global pathology antibody leader, serving customers with a complementary portfolio of immunohistochemistry (IHC), in situ hybridization (ISH) and fluorescence in situ hybridization (FISH) solutions designed to support improved patient health outcomes across oncology and broader clinical pathology. With more tha...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25.02.26 - 23:01
|
Agilent Technologies Reports Drop In Q1 Profit (AFX)
|
|
|
SANTA CLARA (dpa-AFX) - Agilent Technologies (A) reported earnings for first quarter that Drops, from the same period last yearThe company's earnings totaled $305 million, or $1.07 per share. This......
|
|
|
|